Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
What’s a fair price for remdesivir? How do we know whether vaccines work? And does AI have a place in end-of-life care?